![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1040.jpg)
New perspectives and future directions:
Combination of PCI + maintenance Sunitib?
Progression Free Survival
Overall Survival
Trends toward improved OS were seen in patients receiving PCI and Sunitinib
These results support the need for further prospective studies evaluating the
integration of maintenance systemic therapy and PCI in ED-SCLC
Salama JK. et al. J Thor Oncol 2015;11